1. Home
  2. GH vs HTHT Comparison

GH vs HTHT Comparison

Compare GH & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.85

Market Cap

14.8B

Sector

Health Care

ML Signal

HOLD

Logo H World Group Limited

HTHT

H World Group Limited

HOLD

Current Price

$51.93

Market Cap

14.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
HTHT
Founded
2011
2005
Country
United States
China
Employees
N/A
N/A
Industry
Medical Specialities
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
14.8B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
GH
HTHT
Price
$101.85
$51.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
2
Target Price
$102.81
$47.00
AVG Volume (30 Days)
2.1M
1.4M
Earning Date
02-19-2026
03-19-2026
Dividend Yield
N/A
3.52%
EPS Growth
N/A
7.24
EPS
N/A
1.76
Revenue
$902,569,000.00
$3,484,239,807.00
Revenue This Year
$35.23
$7.12
Revenue Next Year
$27.38
$6.64
P/E Ratio
N/A
$28.74
Revenue Growth
30.38
5.77
52 Week Low
$34.88
$30.20
52 Week High
$120.74
$51.46

Technical Indicators

Market Signals
Indicator
GH
HTHT
Relative Strength Index (RSI) 38.60 55.64
Support Level $97.88 $46.84
Resistance Level $118.00 $50.89
Average True Range (ATR) 5.67 1.34
MACD -1.94 -0.06
Stochastic Oscillator 11.61 76.11

Price Performance

Historical Comparison
GH
HTHT

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About HTHT H World Group Limited

H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.

Share on Social Networks: